XML 61 R51.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS - Narrative (Details)
€ in Millions
3 Months Ended
Mar. 04, 2021
USD ($)
Mar. 04, 2021
EUR (€)
Oct. 23, 2020
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Mar. 04, 2021
EUR (€)
Forty Seven, Inc.                
Business Combination, Separately Recognized Transactions [Line Items]                
Consideration, net of acquired cash         $ 4,700,000,000      
Acquired share-based compensation expense         144,000,000      
Three-Year Senior Term Loan Facility | Medium-term Notes                
Business Combination, Separately Recognized Transactions [Line Items]                
Borrowing from senior unsecured term loan facility       $ 1,000,000,000.0        
Acquired IPR&D | Forty Seven, Inc.                
Business Combination, Separately Recognized Transactions [Line Items]                
Impairment charge         $ 4,500,000,000      
MYR GmbH                
Business Combination, Separately Recognized Transactions [Line Items]                
Acquisition consideration transferred $ 1,600,000,000 € 1,300            
Cash paid for acquisition 1,200,000,000 € 1,000            
Fair value of contingent liability 341,000,000              
Finite-lived intangible assets 845,000,000              
Goodwill 226,000,000              
Expected tax deductible goodwill           $ 0    
MYR GmbH | Maximum                
Business Combination, Separately Recognized Transactions [Line Items]                
Liability for MYR GmbH contingent consideration | €               € 300
MYR GmbH | Hepcludex For HDV                
Business Combination, Separately Recognized Transactions [Line Items]                
Finite-lived intangible assets $ 845,000,000              
Weighted average useful life 10 years 10 years            
MYR GmbH | Hepcludex For HDV | Discount Rate                
Business Combination, Separately Recognized Transactions [Line Items]                
Measurement input 0.12             0.12
MYR GmbH | Acquired IPR&D                
Business Combination, Separately Recognized Transactions [Line Items]                
Acquired IPR&D $ 1,190,000,000           $ 1,200,000,000  
MYR GmbH | Acquired IPR&D | Discount Rate                
Business Combination, Separately Recognized Transactions [Line Items]                
Measurement input 0.12             0.12
Immunomedics                
Business Combination, Separately Recognized Transactions [Line Items]                
Acquisition consideration transferred     $ 20,600,000,000          
Goodwill     3,991,000,000          
Immunomedics | Acquired IPR&D                
Business Combination, Separately Recognized Transactions [Line Items]                
Acquired IPR&D     $ 15,760,000,000